Duchenne Muscular Dystrophy | 18-Month DMD Trial Outcomes
SponsoredSee motor function data from a mutation-agnostic therapy with established safety profile. L…Patient Copay Program · Request a Rep · Dosing Schedule · Mechanism of Action
Service catalog: Support Through ITF ARC, Primary Endpoint, Key Secondary EndpointsELEVIDYS (delandistrogene | moxeparvovec-rokl)
SponsoredWatch Helpful Videos to Learn More About Treatment Support, How ELEVIDYS Works, a…

Feedback